Research keywords (4):
臨床薬理
, 薬物代謝
, Clinical Pharmacology
, Drug Metabolism
Research theme for competitive and other funds (17):
2021 - 2024 がん患者における健康食品と医薬品併用の安全性に関する研究
2016 - 2019 Research for safe use of herbal supplements -investigation of the adverse effects of combined use with medicines
2012 - 2015 The appropriate use of OTC drugs in multiple medication.
2011 - 2013 Educational effects of 6 years of consistent educational programs to train medical professions for a team-based medical care
2010 - 2012 Association between genetic polymorphisms of drug-metabolizingenzymes and factors of liver cancer
2000 - 2001 Evaluation of Drug-metabolizing enzyme activity and-drug interaction in paitients with hepatic disease
1999 - 2000 Evaluation of reliability of human liver surgical samples from hepatocellular carcinoma and metastatic cancer patients on the application to the drug-metabolism study
1997 - 2000 Evaluation of pharmacodynamics of drugs acting on the central nervous system using computer-assisted eye movement analysis.
1998 - 1999 Study of the effects of antineoplastic agents on drug metabolizing enzymes and evaluation of its efficacy and safety
1996 - 1997 Polymorphism of drug-metabolising enzymes
1994 - 1995 Polymorphism of drug-metabolyzing enzymes and the assessment of drug efficacy and safety
薬物代謝の遺伝多型
慢性腎不全の薬物代謝酵素に対する影響
マイクロダイアリシス法による薬物動態の検討
Polymorphic drugmetabolism
Effect of Chronic renan failure status on drug-metabolyzing enzymes
Assessment of Plurmacokinetics employing the Microdialysis method
Show all
Papers (45):
Koichiro Shinya, Yuki Nishimura, Kakei Ryu, Takehiko Sambe, Masaya Fujishiro, Akihiro Nakauchi, Yumika Kashiwabuchi, Mariko Iwase, Hirokazu Chokki, Norimitsu Kurata, et al. Short-term administration of Polypodium leucotomos extract does not inhibit CYP3A4-mediated metabolism of midazolam in healthy subjects: an open-label, two-period, fixed-sequence study. International journal of dermatology. 2022
Yumika Kashiwabuchi, Yuki Nishimura, Norimitsu Kurata, Mariko Iwase, Yuji Kiuchi, Koji Nobe. Inhibition of CYP3A-mediated Midazolam Metabolism by <i>Kaempferia Parviflora</i>. Food Safety. 2022. 10. 1. 32-41